Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany

Abstract Introduction Worldwide about 30% of HIV-infected patients are coinfected with HCV or HBV. The HIV/HCV coinfection is more common in individuals who have a history of drug addiction. The aims of this study were to assess the HCV and HBV prevalence in HIV-infected patients and analyze their characteristics. Methods We considered the new HIV diagnoses notified by the regional surveillance system of Tuscany from 2009 to 2013. Descriptive analyses were conducted on the socio-demographic characteristics, routes of transmission, and reason to perform the test. In coinfected patients we assessed the risk for being late presenter (LP) or the risk of having AIDS. Results In 5 years of surveillance a total of 1354 new HIV diagnoses were notified: 1188 (87.7%) were HIV alone, 106 (7.8%) HIV/HCV, 56 (4.1%) HIV/HBV, and 4 (0.33%) HIV/HCV/HBV. The main risk factor was injection drug use in 52.8% of HCV/HIV cases, while in HIV/HBV patients the main risk factor was sexual exposure. HIV/HBV coinfected patients showed worse clinical and immunological features than HIV and HIV/HCV patients: 78.6% had CD4 count less than 350 mm−3 (vs. 54.6% and 62.1%, respectively) and 39.4% had AIDS (vs 20.7% and 7.6%). The risk for being LP triples for HIV/HBV (OR 2.98; 95% IC: 1.56–5.70) than patients with HIV alone. Conclusions We have observed less advanced disease in HIV and HCV-HIV patients compared with HBV–HIV coinfected patients. Moreover, our results show a higher prevalence of HIV/HCV among drug addicts and in the age-group 35–59, corresponding to those born in years considered most at risk for addiction. This study also confirms the finding of a less advanced HIV disease in HIV/HCV coinfected patients.

Saved in:
Bibliographic Details
Main Authors: Puglia,Monia, Stasi,Cristina, Da Frè,Monica, Voller,Fabio
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400330
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702016000400330
record_format ojs
spelling oai:scielo:S1413-867020160004003302016-11-11Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in TuscanyPuglia,MoniaStasi,CristinaDa Frè,MonicaVoller,Fabio HIV HBV HCV Coinfections Abstract Introduction Worldwide about 30% of HIV-infected patients are coinfected with HCV or HBV. The HIV/HCV coinfection is more common in individuals who have a history of drug addiction. The aims of this study were to assess the HCV and HBV prevalence in HIV-infected patients and analyze their characteristics. Methods We considered the new HIV diagnoses notified by the regional surveillance system of Tuscany from 2009 to 2013. Descriptive analyses were conducted on the socio-demographic characteristics, routes of transmission, and reason to perform the test. In coinfected patients we assessed the risk for being late presenter (LP) or the risk of having AIDS. Results In 5 years of surveillance a total of 1354 new HIV diagnoses were notified: 1188 (87.7%) were HIV alone, 106 (7.8%) HIV/HCV, 56 (4.1%) HIV/HBV, and 4 (0.33%) HIV/HCV/HBV. The main risk factor was injection drug use in 52.8% of HCV/HIV cases, while in HIV/HBV patients the main risk factor was sexual exposure. HIV/HBV coinfected patients showed worse clinical and immunological features than HIV and HIV/HCV patients: 78.6% had CD4 count less than 350 mm−3 (vs. 54.6% and 62.1%, respectively) and 39.4% had AIDS (vs 20.7% and 7.6%). The risk for being LP triples for HIV/HBV (OR 2.98; 95% IC: 1.56–5.70) than patients with HIV alone. Conclusions We have observed less advanced disease in HIV and HCV-HIV patients compared with HBV–HIV coinfected patients. Moreover, our results show a higher prevalence of HIV/HCV among drug addicts and in the age-group 35–59, corresponding to those born in years considered most at risk for addiction. This study also confirms the finding of a less advanced HIV disease in HIV/HCV coinfected patients.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.20 n.4 20162016-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400330en10.1016/j.bjid.2015.11.007
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Puglia,Monia
Stasi,Cristina
Da Frè,Monica
Voller,Fabio
spellingShingle Puglia,Monia
Stasi,Cristina
Da Frè,Monica
Voller,Fabio
Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
author_facet Puglia,Monia
Stasi,Cristina
Da Frè,Monica
Voller,Fabio
author_sort Puglia,Monia
title Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
title_short Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
title_full Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
title_fullStr Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
title_full_unstemmed Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
title_sort prevalence and characteristics of hiv/hbv and hiv/hcv coinfections in tuscany
description Abstract Introduction Worldwide about 30% of HIV-infected patients are coinfected with HCV or HBV. The HIV/HCV coinfection is more common in individuals who have a history of drug addiction. The aims of this study were to assess the HCV and HBV prevalence in HIV-infected patients and analyze their characteristics. Methods We considered the new HIV diagnoses notified by the regional surveillance system of Tuscany from 2009 to 2013. Descriptive analyses were conducted on the socio-demographic characteristics, routes of transmission, and reason to perform the test. In coinfected patients we assessed the risk for being late presenter (LP) or the risk of having AIDS. Results In 5 years of surveillance a total of 1354 new HIV diagnoses were notified: 1188 (87.7%) were HIV alone, 106 (7.8%) HIV/HCV, 56 (4.1%) HIV/HBV, and 4 (0.33%) HIV/HCV/HBV. The main risk factor was injection drug use in 52.8% of HCV/HIV cases, while in HIV/HBV patients the main risk factor was sexual exposure. HIV/HBV coinfected patients showed worse clinical and immunological features than HIV and HIV/HCV patients: 78.6% had CD4 count less than 350 mm−3 (vs. 54.6% and 62.1%, respectively) and 39.4% had AIDS (vs 20.7% and 7.6%). The risk for being LP triples for HIV/HBV (OR 2.98; 95% IC: 1.56–5.70) than patients with HIV alone. Conclusions We have observed less advanced disease in HIV and HCV-HIV patients compared with HBV–HIV coinfected patients. Moreover, our results show a higher prevalence of HIV/HCV among drug addicts and in the age-group 35–59, corresponding to those born in years considered most at risk for addiction. This study also confirms the finding of a less advanced HIV disease in HIV/HCV coinfected patients.
publisher Brazilian Society of Infectious Diseases
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400330
work_keys_str_mv AT pugliamonia prevalenceandcharacteristicsofhivhbvandhivhcvcoinfectionsintuscany
AT stasicristina prevalenceandcharacteristicsofhivhbvandhivhcvcoinfectionsintuscany
AT dafremonica prevalenceandcharacteristicsofhivhbvandhivhcvcoinfectionsintuscany
AT vollerfabio prevalenceandcharacteristicsofhivhbvandhivhcvcoinfectionsintuscany
_version_ 1756416524829065216